Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis

Attila Enyedi, Alexandra Csongrádi, István T. Altorjay, Gergő L. Beke, Csongor Váradi, Enikő E. Enyedi, Dorina R. Kiss, Emese Bányai, Edit Kalina, János Kappelmayer, Attila Tóth, Zoltán Papp, István Takács, Miklós Fagyas

Research output: Contribution to journalArticle

Abstract

Establishing the diagnosis of sarcoidosis most often requires biopsy and histopathologic evaluation, since there is no single marker with sufficient specificity and sensitivity for the disease. Our aims were to determine and compare the diagnostic accuracies of several potential biomarkers and to develop a combined biomarker analysis tool for the diagnosis of sarcoidosis. 133 healthy individuals and 104 patients with suspected sarcoidosis and diagnostic thoracic surgery were enrolled into this study. Histopathologic results were contrasted to biomarker levels of chitotriosidase (CTO), serum amyloid-A (SAA), soluble interleukin-2 receptor (sIL-2R), lysozyme (LZM) or angiotensin converting enzyme (ACE). Sarcoidosis was confirmed by histopathology in 69 patients. CTO activity, sIL-2R concentration and ACE activity could discriminate between sarcoidosis and control patients, while SAA and LZM concentrations could not. A new combined parameter, which was derived from the multiplication of ACE by CTO activities (double product) showed the best diagnostic accuracy in this clinical study: (AUC = 0.898, sensitivity: 90.5%, specificity: 79.3%, positive and negative predictive values: 90.5% and 79.3%, respectively). Sarcoidosis can be diagnosed with the combined analysis of ACE and CTO activities more accurately than with single serum biomarkers in the absence of invasive biopsy in the majority of cases with pulmonary manifestation of sarcoidosis.

Original languageEnglish
Pages (from-to)155-162
Number of pages8
JournalClinica Chimica Acta
Volume500
DOIs
Publication statusPublished - Jan 2020

    Fingerprint

Keywords

  • ACE
  • Chitotriosidase
  • Diagnostic accuracy
  • Double product
  • Sarcoidosis

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Enyedi, A., Csongrádi, A., Altorjay, I. T., Beke, G. L., Váradi, C., Enyedi, E. E., Kiss, D. R., Bányai, E., Kalina, E., Kappelmayer, J., Tóth, A., Papp, Z., Takács, I., & Fagyas, M. (2020). Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis. Clinica Chimica Acta, 500, 155-162. https://doi.org/10.1016/j.cca.2019.10.010